Krensavage Asset Management as of Dec. 31, 2019
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 12 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) | 13.8 | $41M | 461k | 88.08 | |
Regeneron Pharmaceuticals (REGN) | 13.4 | $39M | 104k | 375.48 | |
McKesson Corporation (MCK) | 12.0 | $35M | 254k | 138.32 | |
Alexion Pharmaceuticals | 11.6 | $34M | 314k | 108.15 | |
Biogen Idec (BIIB) | 11.1 | $33M | 110k | 296.73 | |
Enanta Pharmaceuticals (ENTA) | 10.3 | $30M | 489k | 61.78 | |
Taro Pharmaceutical Industries (TARO) | 10.2 | $30M | 340k | 87.93 | |
Alkermes (ALKS) | 6.3 | $19M | 905k | 20.40 | |
RTI Biologics | 3.4 | $9.9M | 3.6M | 2.74 | |
Invacare Corporation | 2.7 | $7.9M | 880k | 9.02 | |
Gilead Sciences (GILD) | 2.7 | $7.9M | 122k | 64.98 | |
Anaptysbio Inc Common (ANAB) | 2.4 | $7.2M | 440k | 16.25 |